Esperion Completes Patient Enrollment in Global Pivotal Phase 3 Program for Bempedoic Acid

October 2, 2017

Pivotal Phase 3 Top-Line Results for Bempedoic Acid Expected in the Second and Third Quarters of 2018
More »

FierceBiotech's 2017 Fierce 15

September 26, 2017

Axial Biotherapeutics selected in FierceBiotech's 2017 Fierce 15
More »

IntegenX Applauds the Passage of the Rapid DNA Act of 2017

August 21, 2017

Amendment of the DNA Identification Act of 1994 is a substantial step forward in making real-time DNA testing of arrestees in the booking environment a reality
More »